57 related articles for article (PubMed ID: 14506730)
1. Can screening for cervical cancer be improved, especially in developing countries?
Miller AB; Sankaranarayanan R; Bosch FX; Sepulveda C
Int J Cancer; 2003 Nov; 107(3):337-40. PubMed ID: 14506730
[No Abstract] [Full Text] [Related]
2. Visual inspection with acetic acid in cervical cancer screening.
Ardahan M; Temel AB
Cancer Nurs; 2011; 34(2):158-63. PubMed ID: 21326031
[TBL] [Abstract][Full Text] [Related]
3. [Extend screening for cervical cancer! Improved diagnosis with papillomavirus test and colposcopy].
Rubinstein E
Lakartidningen; 1996 Jan; 93(5):365-6, 369. PubMed ID: 8628068
[No Abstract] [Full Text] [Related]
4. Translational approaches to improving cervical screening.
Baldwin P; Laskey R; Coleman N
Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
[TBL] [Abstract][Full Text] [Related]
5. Developing countries put cervical cancer tests to the test.
Wang L
J Natl Cancer Inst; 2002 Feb; 94(4):245-7. PubMed ID: 11854383
[No Abstract] [Full Text] [Related]
6. Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer.
Kumar K; Iyer VK; Bhatla N; Kriplani A; Verma K
Indian J Med Res; 2007 Jul; 126(1):39-44. PubMed ID: 17890822
[TBL] [Abstract][Full Text] [Related]
7. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
8. [Colposcopic and cytological diagnosis of subclinical papillomavirus infections from the aspect of biopsies and hybridization tests].
Kanka J; Beková A; Brichácek B; Havránková A; Hirsch I; Krcmár M; Náprstková J; Rychterová J; Svoboda B; Vonka V
Cesk Gynekol; 1990 Mar; 55(2):109-13. PubMed ID: 2160863
[No Abstract] [Full Text] [Related]
9. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
10. Re: Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
Gaikwad NL; Mahajan NN; Mahajan KN
Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):258-9; author reply 259. PubMed ID: 17550500
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of cervical-cancer screening in developing countries.
Suba EJ; Frable WJ; Raab SS
N Engl J Med; 2006 Apr; 354(14):1535-6; author reply 1535-6. PubMed ID: 16598056
[No Abstract] [Full Text] [Related]
12. Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting.
Tebeu PM; Fokom-Domgue J; Crofts V; Flahaut E; Catarino R; Untiet S; Vassilakos P; Petignat P
Int J Cancer; 2015 Mar; 136(6):E743-50. PubMed ID: 25284599
[TBL] [Abstract][Full Text] [Related]
13. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
15. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
16. A comparison of simultaneous cervical cytology, HPV testing, and colposcopy.
Hockstad RL
Fam Pract Res J; 1992 Mar; 12(1):53-60. PubMed ID: 1312758
[TBL] [Abstract][Full Text] [Related]
17. Colposcopy, cervical screening, and HPV. Preface.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
[No Abstract] [Full Text] [Related]
18. Colposcopy at a crossroads.
Jeronimo J; Schiffman M
Am J Obstet Gynecol; 2006 Aug; 195(2):349-53. PubMed ID: 16677597
[TBL] [Abstract][Full Text] [Related]
19. [Status of screening tests for cervical cancer and its precancerous lesion].
Zhao FH; Rong SD; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
[TBL] [Abstract][Full Text] [Related]
20. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
